CIK 0001684693 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in L3 · fiscal year ends 12/31
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-06 | 6-K | 6-K | 2026-10-06 |
| 2026-09-30 | 6-K | 6-K | 2026-09-30 |
| 2026-09-17 | 6-K | 6-K | 2026-09-17 |
| 2026-09-14 | 4 | 4 | 2026-09-10 |
| 2026-09-09 | 4 | 4 | 2026-09-04 |
| 2026-09-03 | 4 | 4 | 2026-09-01 |
| 2026-08-31 | 4 | 4 | 2026-08-28 |
| 2026-08-20 | 6-K | 6-K | 2026-06-30 |
| 2026-08-14 | 4 | 4 | 2026-08-12 |
| 2026-07-15 | 4 | 4 | 2026-07-13 |
| 2026-07-10 | 4 | 4 | 2026-07-08 |
| 2026-07-02 | 4 | 4 | 2026-07-01 |
| 2026-06-09 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-05-28 | 6-K | 6-K | 2026-05-28 |
| 2026-05-22 | 4 | 4 | 2026-05-20 |
| 2026-05-14 | 4 | 4 | 2026-05-12 |
| 2026-05-06 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-04-15 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-03-31 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-03-24 | 6-K | 6-K | 2026-03-24 |
| 2026-03-24 | 424B5 | 424B5 | |
| 2026-03-24 | 4 | 4 | 2026-03-24 |
| 2026-03-23 | EFFECT | EFFECT items ,, | |
| 2026-03-23 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-03-19 | POS AM | POS AM |
Forms on file (last 1,000): 6-K 160, 4 24, 3 12, 144 10, CORRESP 10, UPLOAD 10, EFFECT 9, 20-F 9. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=SLGL (0.002 USD), /gw/filings/filings?ticker=SLGL&form=8-K, /gw/filings/facts?ticker=SLGL&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange